Northwestern Mutual Wealth Management Co. Sells 15,248 Shares of SPDR S&P Biotech ETF $XBI

Northwestern Mutual Wealth Management Co. cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,278 shares of the exchange traded fund’s stock after selling 15,248 shares during the quarter. Northwestern Mutual Wealth Management Co. owned about 0.22% of SPDR S&P Biotech ETF worth $9,809,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in XBI. Banque Cantonale Vaudoise bought a new position in shares of SPDR S&P Biotech ETF in the 1st quarter valued at about $67,000. Commerce Bank raised its holdings in shares of SPDR S&P Biotech ETF by 36.5% in the 1st quarter. Commerce Bank now owns 4,356 shares of the exchange traded fund’s stock valued at $353,000 after purchasing an additional 1,164 shares during the period. Banco Santander S.A. lifted its stake in SPDR S&P Biotech ETF by 35.9% in the 1st quarter. Banco Santander S.A. now owns 19,739 shares of the exchange traded fund’s stock valued at $1,601,000 after purchasing an additional 5,218 shares during the last quarter. Avalon Trust Co bought a new position in SPDR S&P Biotech ETF during the first quarter worth about $57,000. Finally, Goldman Sachs Group Inc. grew its holdings in SPDR S&P Biotech ETF by 33.0% during the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after purchasing an additional 3,353,029 shares during the period.

SPDR S&P Biotech ETF Stock Down 2.7%

NYSEARCA:XBI opened at $119.85 on Tuesday. The stock’s 50 day moving average price is $109.41 and its two-hundred day moving average price is $94.67. The firm has a market capitalization of $7.27 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $123.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.